ARCHIVES

Navelbine+Herceptin: 78% Response In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

National Coalition Dinner Honors Cancer Program Founders, Advocates, And Cancer Survivors

March 6, 1992

DFA Proposes Controversial Guidelines For Clinical Tests

November 21, 1975

NIH Scientists May Take Payment For Outside Teaching, Writing, Ethics Office Says In Final Rule

September 11, 1992

Technology Isolates and Recovers Circulating Liver Tumor Cells

April 27, 2012

Trials Approved by NCI CTEP Last Month

November 25, 2011

Also FDA clarifies data requirements for phase I IND applications.

April 29, 2005